Find us online

Portfolio

light-dna-spring

ElevateBio removes barriers, accelerating the development of visionary therapies.

Committed to identifying and nurturing
innovation in cell and gene therapy

Our portfolio companies benefit from our entrepreneurial and flexible culture. We accelerate early-stage companies through capital and expertise, allowing them to focus on science, research, and development.

Viralym-M (ALVR105)
Multi-VSTs targeting BK Virus (BKV), Cytomegalovirus (CMV), Adenovirus (AdV), Epstein-Barr (EBV), and Human Herpesvirus-6 (HHV-6)

Target Indication

Preclinical

POC Trial (Phase 1b/2)

Pivotal Trial (Phase 3)

Treatment of Virus-Associated Hemorrhagic-Cystitis
Treatment of CMV
Treatment of ADV
Prevention of BKV, CMV, AdV, EBV, HHV-6 and JCV
Treatment of BKV
Treatment of CMV

ALVR106
Multi-VSTs targeting Respiratory syncytial virus (RSV), Influenza, Parainfluenza Virus (PIV), and Human Metapneumovirus (hMPV)

Target Indication

Preclinical

POC Trial (Phase 1b/2)

Pivotal Trial (Phase 3)

Treatment of RSV, Influenza, PIV, & hMPV
Treatment of RSV, Influenza, PIV, & hMPV

ALVR109
Single-VST targeting SARS-CoV-2

Target Indication

Preclinical

POC Trial (Phase 1b/2)

Pivotal Trial (Phase 3)

Treatment of COVID-19

ALVR107
Single-VST targeting Hepatitis B (HBV)

Target Indication

Preclinical

POC Trial (Phase 1b/2)

Pivotal Trial (Phase 3)

Treatment of HBV

ALVR108
Single-VST targeting Human Herpesvirus-8 (HHV-8)

Target Indication

Preclinical

POC Trial (Phase 1b/2)

Pivotal Trial (Phase 3)

Treatment of HHV-8
Highpass Logo

HA-1 TCR
T cell receptor (TCR) T cell therapy targeting HA-1 expressing tumors designed to manage post-hematopoietic stem cell transplant leukemic relapse

Indication

Preclinical

Phase 1

Phase 2

Phase 3

HA-1 T TCR T Cell Immunotherapy for the Treating of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

We’re the partner of choice for the world’s most innovative academic researchers and entrepreneurs.

Building an alliance with Massachusetts General Hospital 

The strategic partnership gives MGH preferred access to ElevateBio’s BaseCamp research, process development, and manufacturing facility. ElevateBio will support a variety of cell and gene therapy programs from MGH’s research programs, working to identify cell and gene technologies at university labs.

Learn More

Academic researchers provide the vision, we provide the acceleration. 

We’re pioneering new methods to develop next generation, cell, viral, and regenerative therapies. BaseCamp offers expertise to our portfolio companies and partners to accelerate the development of cell and gene therapies, from cGMP manufacturing suites to protein engineering, virology, and immunology labs.

Explore Basecamp

Work with a team that delivers decades of experience

Meet the scientists and operators that bring decades of their shared knowledge to the development of life-transforming cell and gene therapies. Their know-how moves potential product candidates from concept to commercialization.

Meet the team
Mellisa Carpenter, PhD

Melissa Carpenter, PhD
Chief Scientific Officer of Regenerative Medicine

Mitch Finer

MITCHELL H. FINER, PHD
CHIEF SCIENTIFIC OFFICER OF ELEVATEBIO AND PRESIDENT OF BASECAMP

Mike Paglia

Michael Paglia, MSc
SVP, CMC Operations

Doug Chambers

Doug Chambers
VP, Quality

footer-logo
light-dna-spring

Navigation

Privacy & Cookie Policy

BaseCamp

200 Smith St
Suite 301
Waltham MA 02451

Cambridge

139 Main Street
Suite 500
Cambridge, MA 02142

Digital

Main Number
617-433-2600

Connect
Careers
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google